Company Filing History:
3 out of 541 
1 out of 4,179 
Years Active: 2018-2020
Title: Innovative Contributions of Lydia Greenlees in Biomedical Technology
Introduction: Lydia Greenlees is a notable inventor based in Gaithersburg, Maryland. With a remarkable track record of three patents, she has made significant contributions to the field of biomedical technology, particularly in the development of assays for disease detection and recombinant polypeptide production.
Latest Patents: Greenlees' latest patents showcase her innovative approach to solving complex medical challenges. One of her key inventions is a method that utilizes antibodies to determine periostin levels in samples. This invention offers a robust, sensitive, and specific assay for the detection and measurement of periostin levels in patients with IL-13-mediated diseases or disorders. Additionally, her patent introduces novel antiperiostin monoclonal antibodies that target various isoforms of human periostin, along with assay kits that contain one or more of these antibodies. Another notable patent involves the production of recombinant polypeptides in mammalian cell culture, where she outlines methods to modify microRNA activity levels, enhancing the efficiency of polypeptide production.
Career Highlights: Lydia has had a successful career working with prominent companies in the industry. She has spent valuable time at Medimmune Limited and Abbott Laboratories Corporation, where she honed her skills and expertise in biotechnology and pharmaceutical development.
Collaborations: Throughout her career, Greenlees has collaborated with talented professionals, including Katie Streicher and Koustubh Ranade. These collaborations have likely helped to enhance her research and development efforts, leading to her significant contributions in her field.
Conclusion: In summary, Lydia Greenlees exemplifies the spirit of innovation through her substantial patents and collaborations. Her work in antibody assays and recombinant polypeptide production underscore her commitment to advancing biomedical technology, ultimately contributing to better diagnostic and therapeutic solutions in healthcare. Her journey serves as an inspiration for future inventors and researchers in the field.